Coverage
-
January 11, 2023
A federal judge has refused to throw out Bionpharma's allegations that Azurity Pharmaceuticals Inc. filed a series of anti-competitive lawsuits over a blood pressure drug, saying it was too early to rule on various factual issues.
1 other articles on this case.
View all »